222 related articles for article (PubMed ID: 15058251)
1. [Thrombomodulin, von Willebrand factor and tissue plasminogen activator in the blood plasma of obese women and men].
Rość D; Drewniak W; Kinasz-Rózycka I; Kulwas A; Michalski A
Pol Merkur Lekarski; 2003 Dec; 15(90):518-20. PubMed ID: 15058251
[TBL] [Abstract][Full Text] [Related]
2. Endothelial cell activation in cutaneous vasculitis.
Jurd KM; Stephens CJ; Black MM; Hunt BJ
Clin Exp Dermatol; 1996 Jan; 21(1):28-32. PubMed ID: 8689765
[TBL] [Abstract][Full Text] [Related]
3. [Markers of endothelial stimulation in hyperthyroidism].
Rość D; Drewniak W; Zastawna E; Paczuski R; Graczykowska-Koczorowska A
Pol Merkur Lekarski; 1999 Feb; 6(32):79-81. PubMed ID: 10337177
[TBL] [Abstract][Full Text] [Related]
4. Endothelial haemostatic markers in members of families with familial combined hyperlipidemia.
Karásek D; Vaverková H; Halenka M; Slavík L; Novotný D
Thromb Res; 2009; 123(3):466-75. PubMed ID: 18417194
[TBL] [Abstract][Full Text] [Related]
5. Is visceral adipose tissue a determinant of von Willebrand factor in overweight and obese premenopausal women?
Mertens I; Van der Planken M; Corthouts B; Van Gaal LF
Metabolism; 2006 May; 55(5):650-5. PubMed ID: 16631442
[TBL] [Abstract][Full Text] [Related]
6. Plasma levels of free and total TFPI, relationship with cardiovascular risk factors and endothelial cell markers.
Morange PE; Renucci JF; Charles MA; Aillaud MF; Giraud F; Grimaux M; Juhan-Vague I
Thromb Haemost; 2001 Jun; 85(6):999-1003. PubMed ID: 11434709
[TBL] [Abstract][Full Text] [Related]
7. Endothelial marker proteins in hyperhomocysteinemia.
de Jong SC; Stehouwer CD; van den Berg M; Vischer UM; Rauwerda JA; Emeis JJ
Thromb Haemost; 1997 Nov; 78(5):1332-7. PubMed ID: 9408014
[TBL] [Abstract][Full Text] [Related]
8. [The influence of ozone therapy on endothelial damage markers in patients with atherosclerosis of lower extremities].
Rość D; Ponikowska I; Paczuski R; Włodarczyk K; Zastawna E; Michalski A
Pol Merkur Lekarski; 1999 Mar; 6(33):135-7. PubMed ID: 10365597
[TBL] [Abstract][Full Text] [Related]
9. [Does extracorporeal circulation during coronary artery bypass grafting damage vascular endothelium?].
Kotschy M; Zekanowska E; Rość D; Missima M; Ogorzeja W; Kotschy D
Pol Merkur Lekarski; 2003 Aug; 15(86):135-9. PubMed ID: 14648977
[TBL] [Abstract][Full Text] [Related]
10. Altered endothelial function following the Fontan procedure.
Binotto MA; Maeda NY; Lopes AA
Cardiol Young; 2008 Feb; 18(1):70-4. PubMed ID: 18093358
[TBL] [Abstract][Full Text] [Related]
11. [Von Willebrand factor in hemodialysed patients with chronic renal failure].
Bronisz M; Rość D; Paczuski R; Nartowicz E; Bronisz A
Pol Merkur Lekarski; 2001 Jul; 11(61):40-3. PubMed ID: 11579829
[TBL] [Abstract][Full Text] [Related]
12. Plasma levels of von Willebrand factor and plasminogen activator in patients with arterial thromboembolism--with special reference to their correlation to the increased catabolism of both fibrinogen and platelets.
Matsumoto M; Uchiyama T; Kobayashi N; Maekawa T
Nihon Ketsueki Gakkai Zasshi; 1989 Sep; 52(6):1105-14. PubMed ID: 2588960
[TBL] [Abstract][Full Text] [Related]
13. Tissue plasminogen activator, von Willebrand factor, and risk of type 2 diabetes in older men.
Wannamethee SG; Sattar N; Rumley A; Whincup PH; Lennon L; Lowe GD
Diabetes Care; 2008 May; 31(5):995-1000. PubMed ID: 18235054
[TBL] [Abstract][Full Text] [Related]
14. von Willebrand factor antigen, tissue-type plasminogen activator antigen, and risk of death in human immunodeficiency virus 1-related clinical disease: independent prognostic relevance of tissue-type plasminogen activator.
Schved JF; Gris JC; Arnaud A; Martinez P; Sanchez N; Wautier JL; Sarlat C
J Lab Clin Med; 1992 Sep; 120(3):411-9. PubMed ID: 1517688
[TBL] [Abstract][Full Text] [Related]
15. Platelet hyperactivation in patients with essential thrombocythemia is not associated with vascular endothelial cell damage as judged by the level of plasma thrombomodulin, protein S, PAI-1, t-PA and vWF.
Bellucci S; Ignatova E; Jaillet N; Boffa MC
Thromb Haemost; 1993 Nov; 70(5):736-42. PubMed ID: 8128427
[TBL] [Abstract][Full Text] [Related]
16. Plasma thrombomodulin in orthotopic liver transplantation.
Boutiere B; Arnoux D; Boffa MC; Samson D; Le Treut YP; Sampol J
Transplantation; 1994 Dec; 58(12):1352-5. PubMed ID: 7809928
[TBL] [Abstract][Full Text] [Related]
17. Comparison of soluble thrombomodulin, von Willebrand factor, tPA/PAI-1 complex, and high-sensitivity CRP concentrations in serum, EDTA plasma, citrated plasma, and acidified citrated plasma (Stabilyte) stored at -70 degrees C for 8-11 years.
Nilsson TK; Boman K; Jansson JH; Thøgersen AM; Berggren M; Broberg A; Granlund A
Thromb Res; 2005; 116(3):249-54. PubMed ID: 15935834
[TBL] [Abstract][Full Text] [Related]
18. [Change of vWF, PAl-1 and t-PA in rats with hyperlipemia and its significance].
Jiang HH; Liu Y; Lin GQ; Li YQ
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 May; 33(5):415-20. PubMed ID: 18544845
[TBL] [Abstract][Full Text] [Related]
19. Sympathoadrenal activation and muscarinic receptor stimulation induce acute release of tissue-type plasminogen activator but not von Willebrand factor across the human forearm.
Jern C; Selin L; Tengborn L; Jern S
Thromb Haemost; 1997 Aug; 78(2):887-91. PubMed ID: 9268190
[TBL] [Abstract][Full Text] [Related]
20. The effects of sex steroids on plasma levels of marker proteins of endothelial cell functioning.
van Kesteren PJ; Kooistra T; Lansink M; van Kamp GJ; Asscheman H; Gooren LJ; Emeis JJ; Vischer UM; Stehouwer CD
Thromb Haemost; 1998 May; 79(5):1029-33. PubMed ID: 9609242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
